Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Routine clinical use of liraglutide 3 mg for the treatment of obesity: outcomes in non-surgical and bariatric surgery patients
If you are uncomfortable with the current valuations of LLY and NVO (dont be, theyre fine), I would recommend looking into more downstream effects where tailwinds provided by these drugs may not be priced in to expectations by the market and/or consensus estimates yet
A small number of countries have limited GLP-1 availability or import restrictions, though most major destinations permit it
Many people say theyre sugar addicts, consuming real sugar and artificial sweeteners in various forms, she adds
